Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Inherited Disease
  • Published:

Hematopoietic stem cell gene therapy leads to marked visceral organ improvements and a delayed onset of neurological abnormalities in the acid sphingomyelinase deficient mouse model of Niemann–Pick disease

Gene Therapy volume 7, pages 1768–1776 (2000)Cite this article

Abstract

Types A and B Niemann–Pick disease (NPD) result from the deficient activity of acid sphingomyelinase (ASM). Currently, no treatment is available for either form of NPD. Using the ASM knockout (ASMKO) mouse model, we evaluated the effects of ex vivo hematopoietic stem cell gene therapy on the NPD phenotype. Thirty-two newborn ASMKO mice were preconditioned with low dose radiation (200 cGy) and transplanted with ASMKO bone marrow cells which had been transduced with an ecotropic retroviral vector encoding human ASM. Engraftment of donor-derived cells ranged from 15 to 60% based on Y-chromosome in situ hybridization analysis of peripheral white blood cells, and was achieved in 92% of the transplanted animals. High levels of ASM activity (up to five-fold above normal) were found in the engrafted animals for up to 10 months after transplantation, and their life-span was extended from a mean of 5 to 9 months by the gene therapy procedure. Biochemical and histological analysis of tissues obtained 4–5 months after transplantation indicated that the ASM activities were increased and the sphingomyelin storage was significantly reduced in the spleens, livers and lungs of the treated mice, major sites of pathology in type B NPD. The presence of Purkinje cell neurons was also markedly increased in the treatment group as compared with non-treated animals at 5 months after transplantation, and a reduction of storage in spinal cord neurons was observed. However, all of the transplanted mice eventually developed ataxia and died earlier than normal mice. Overall, these results indicated that hematopoietic stem cell gene therapy should be effective for the treatment of non-neurological type B NPD, but improved techniques for targeting the transplanted cells and/or expressed enzyme to specific sites of pathology in the central nervous system must be developed in order to achieve effective treatment for type A NPD.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6

Similar content being viewed by others

References

  1. Brady RO, Kanfer JN, Mock MB, Fredrickson DS . The metabolism of sphingomyelin. II: Evidence of an enzymatic deficiency in Niemann–Pick disease Proc Natl Acad Sci USA 1966 55: 366–369

    Article  CAS  Google Scholar 

  2. Schneider PB, Kennedy EP . Sphingomyelinase in normal human spleens and in spleens from subjects with Niemann–Pick disease J Lipid Res 1967 8: 202–209

    CAS  PubMed  Google Scholar 

  3. Schuchman EH, Desnick RJ . Niemann-Pick disease types A and B: acid sphingomyelinase deficiencies. In: Scriver CR, Beaudet A, Sly WS, Valle D (eds) The Metabolic and Molecular Basis of Inherited Disease McGraw-Hill: New York 1995 2601–2624

    Google Scholar 

  4. Schuchman EH, Suchi M, Takahashi T, Sandhoff K, Desnick RJ . Human acid sphingomyelinase: isolation, nucleotide sequence and expression of the full-length and alternatively spliced cDNAs J Biol Chem 1991 266: 8531–8539

    CAS  PubMed  Google Scholar 

  5. Schuchman EH, Levran O, Pereira LV, Desnick RJ . Structural organization and complete nucleotide sequence of the gene encoding human acid sphingomyelinase Genomics 1992 12: 197–205

    Article  CAS  Google Scholar 

  6. Horinouchi K et al. Mouse models of Niemann–Pick disease: mutation analysis and chromosomal mapping rule out the type A and B forms Genomics 1993 18: 450–451

    Article  CAS  Google Scholar 

  7. Newrzella D, Stoffel WS . Molecular cloning of the acid sphingomyelinase of the mouse and the organization of the complete nucleotide sequence of the gene Biol Chem Hoppe Seyler 1992 373: 1233–1238

    Article  CAS  Google Scholar 

  8. Miranda SRP, Schuchman EH . Niemann–Pick disease: mutation update, genotype/phenotype correlations, and prospects for genetic testing Gen Test 1997 1: 13–19

    Article  Google Scholar 

  9. Horinouchi K et al. Acid sphingomyelinase deficient mice: a model of types A and B Niemann–Pick disease Nat Genet 1995 10: 288–296

    Article  CAS  Google Scholar 

  10. Otterbach B, Stoffel W . Acid sphingomyelinase-deficient mice mimic the neurovisceral form of human lysosomal storage disease (Niemann–Pick disease) Cell 1995 81: 1053–1061

    Article  CAS  Google Scholar 

  11. Daloze P et al. Replacement therapy for inherited enzyme deficiency: liver orthotopic transplantation in Niemann–Pick disease type A Am J Med Genet 1977 1: 229–239

    Article  CAS  Google Scholar 

  12. Gartner JC et al. Progression of neurovisceral storage disease with supranuclear ophthalmoplegia following orthotopic liver transplantation Pediatrics 1986 77: 104–106

    PubMed  PubMed Central  Google Scholar 

  13. Scaggiante B et al. Successful therapy of Niemann–Pick disease by implantation of human amniotic membrane Transplantation 1987 44: 59–61

    Article  CAS  Google Scholar 

  14. Vellodi A et al. Treatment of Niemann–Pick disease type B by allogeneic bone marrow transplantation Br Med J Clin Res Ed 1987 295: 1375–1376

    Article  CAS  Google Scholar 

  15. Krivit W et al. Lysosomal storage diseases treated by bone marrow transplantation: review of 21 patients. In: Leonard JF, Pochedly C (eds) Bone Marrow Transplantation in Children Raven Press: New York 1990 pp 261–272

    Google Scholar 

  16. Bayeuer E et al. Bone marrow transplantation for Niemann–Pick type IA disease J Inherit Metab Dis 1992 15: 919–921

    Article  Google Scholar 

  17. Miranda SRP et al. Bone marrow transplantation in acid sphingomyelinase deficient mice: engraftment and cell migration into the brain as a function of radiation, age, and phenotype Blood 1997 90: 444–452

    CAS  PubMed  Google Scholar 

  18. Miranda SRP et al. Biochemical, pathological, and clinical response to transplantation of normal bone marrow cells into acid sphingomyelinase-deficient mice Transplantation 1998 65: 884–892

    Article  CAS  Google Scholar 

  19. Hoogerbrugge PM et al. Allogeneic bone marrow transplantation for lysosomal storage diseases Lancet 1995 345: 1398–1402

    Article  CAS  Google Scholar 

  20. Dao M, Nolta J . Molecular control of cell cycle progression in primary human hematopoietic stem cells: methods to increase levels of retrovirus-mediated transduction Leukemia 1999 13: 1473–1480

    Article  CAS  Google Scholar 

  21. Goerner M et al. The use of granulocyte colony-stimulatingfactor during retroviral transduction on fibronectin fragment CH-296 enhances gene transfer into hematopoietic repopulating cells in dogs Blood 1999 94: 2287–2292

    CAS  PubMed  Google Scholar 

  22. Chuah MK et al. Bone marrow stromal cells as targets for gene therapy of hemophilia A Hum Gene Ther 1998 9: 353–365

    Article  CAS  Google Scholar 

  23. Eliopoulos N et al. Retroviral transfer and long-term expression of the human cytidine deaminase cDNA in hematopoietic cells following transplantation in mice Gene Therapy 1998 5: 1545–1551

    Article  CAS  Google Scholar 

  24. Simonaro CM et al. Autologous transplantation of retrovirally transduced bone marrow or neonatal blood cells into cats can lead to long-term engraftment in the absence of myeloablation Gene Therapy 1999 6: 107–113

    Article  CAS  Google Scholar 

  25. Kuemmel TA, Schroeder R, Stoffel W . Light and electron microscopic analysis of the central and peripheral nervous systems of acid sphingomyelinase-deficient mice resulting from gene targeting J Neuropathol Exp Neurol 1997 56: 171–179

    Article  CAS  Google Scholar 

  26. Furuya S, Mitoma J, Makino A, Hirabayashi Y . Ceramide and its interconvertible metabolite sphingosine function as indispensable lipid factors involved in survival and dendritic differentiation of cerebellar Purkinje cells J Neurochem 1998 71: 366–377

    Article  CAS  Google Scholar 

  27. Arnold DB, Heintz N . A calcium responsive element that regulates expression of two calcium binding proteins in Purkinje cells Proc Natl Acad Sci USA 1997 94: 8842–8847

    Article  CAS  Google Scholar 

  28. German DC et al. Calbindin-D28k in nerve cell nuclei Neuroscience 1997 81: 735–743

    Article  CAS  Google Scholar 

  29. Nakagawa S et al. Cytological compartmentalization in thestaggerer cerebellum, as revealed by calbindin immunohistochemistry for Purkinje cells J Comp Neurol 1998 395: 112–120

    Article  CAS  Google Scholar 

  30. Yeyati PL et al. Fluorescent-based selection of retrovirally transduced cells in the absence of a marker gene: direct selection of transduced type B Niemann–Pick disease cells and evidence for bystander correction Hum Gene Ther 1995 6: 975–983

    Article  CAS  Google Scholar 

  31. Markowitz D, Goff S, Bank A . Construction and use of a safe and efficient amphotropic packaging cell line Virology 1988 167: 400–406

    Article  CAS  Google Scholar 

  32. Fillat C et al. Arylsulfatase B activities and glycosaminoglycan levels in retrovirally transduced mucopolysaccharidosis type VI cells. Prospects for gene therapy J Clin Invest 1996 98: 497–502

    Article  CAS  Google Scholar 

  33. Huang MM et al. Retrovirus-mediated transfer of the human alpha-L-iduronidase cDNA into human hematopoietic progenitor cells leads to correction in trans of Hurler fibroblasts Gene Therapy 1997 4: 1150–1159

    Article  CAS  Google Scholar 

  34. Markowitz D, Goff S, Bank A . A safe packaging line for gene transfer: separating viral genes on two different plasmids J Virol 1988 62: 120–124

    Google Scholar 

  35. Bertoncello I, Bartelmez SH, Bradley TR, Hogson GS . Increased Qa-m7 antigen expression is characteristic of primitive hematopoietic progenitors in regenerating marrow J Immunol 1987 139: 1096–103

    CAS  PubMed  Google Scholar 

  36. Bodine DM, Seidel N, Karlsson S, Nienhius W . The combination of IL-3 and IL-6 enhances retrovirus-mediated gene transfer into hematopoietic stem cells Prog Clin Biol Res 1990 352: 287–299

    CAS  PubMed  Google Scholar 

  37. Okada S et al. Enrichment and characterization of murine hematopoietic stem cells that express c-kit molecule Blood 1991 78: 1706–1712

    CAS  PubMed  Google Scholar 

  38. Brugger W et al. Ex vivo expansion of enriched peripheral blood CD34+ progenitor cells by stem cell factor, interleukin-1 beta (IL-1 beta), IL-6, IL-3, interferon-gamma, and erythropoietin Blood 1993 81: 2579–2584

    CAS  Google Scholar 

  39. Koller MR, Bender JG, Miller WM, Papoutsakis ET . Expansion of primitive human hematopoietic progenitors in a perfusion bioreactor system with IL-3, IL-6, and stem cell factor Biotechnology 1993 11: 358–363

    Article  CAS  Google Scholar 

  40. Singh L, Panicker SG, Nagaraj R, Majundar KC . Banded krait minor-satellite (Bkm)-associated Y chromosome specific repetitive DNA in mouse Nucleic Acid Res 1994 22: 2289–2295

    Article  CAS  Google Scholar 

  41. Dinur T et al. Toward gene therapy for Niemann–Pick disease (NPD): separation of retrovirally corrected and non-corrected NPD fibroblasts using a novel fluorescent sphingomyelin Hum Gene Ther 1992 3: 633–640

    Article  CAS  Google Scholar 

  42. Stein S et al. Amino acid analysis with fluorescamine at the picomole level Arch Biochem Biophys 1973 155: 202–209

    Article  CAS  Google Scholar 

  43. Schissel SL, Schuchman EH, Williams KJ, Tabas I . Zn2+-stimulated sphingomyelinase is secreted by many cell types and is a product of the acid sphingomyelinase gene J Biol Chem 1996 271: 18431–18439

    Article  CAS  Google Scholar 

  44. Rousseau A, Livni N, Gatt S . Utilization of membranous lipid substrates by membranous enzymes: activation of the latent sphingomyelinase of hen erythrocyte membrane Arch Biochem Biophys 1986 244: 838–844

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This work was supported by research grants from the National Institute of Health (HD 28607 and HD 32654), March of Dimes Birth Defects Foundation (1–2224), a grant (RR 0071) from the National Center for Research Resources for the Mount Sinai General Clinical Research Center, and a grant (93–00015) from the US–Israel Binational Science Foundation. We would like to thank Dr Lalji Singh, from the Center for Cellular and Molecular Biology (India), for providing the Y chromosome-specific probe.

Author information

Authors and Affiliations

  1. Department of Human Genetics, Mount Sinai School of Medicine, New York, NY, USA

    S R P Miranda, S Erlich & E H Schuchman

  2. Institute for Gene Therapy and Molecular Medicine, Mount Sinai School of Medicine, New York, NY, USA

    E H Schuchman

  3. Brookdale Center for Molecular Biology, Mount Sinai School of Medicine, New York, NY, USA

    V L Friedrich Jr

  4. Department of Biochemistry, Hebrew University-Hadassah School of Medicine, Jerusalem, Israel

    S Gatt

Authors
  1. S R P Miranda
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S Erlich
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. V L Friedrich Jr
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. S Gatt
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. E H Schuchman
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Miranda, S., Erlich, S., Friedrich, V. et al. Hematopoietic stem cell gene therapy leads to marked visceral organ improvements and a delayed onset of neurological abnormalities in the acid sphingomyelinase deficient mouse model of Niemann–Pick disease. Gene Ther 7, 1768–1776 (2000). https://doi.org/10.1038/sj.gt.3301300

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.gt.3301300

Keywords

This article is cited by

Search

Advanced search

Quick links